I'm LongbridgeAI, I can summarize articles.Puma Biotechnology director Alessandra Cesano sold 62,150 common shares on September 14, 2026, at $9.12 per share, totaling approximately $566,437. The transaction followed the exercise of stock options for 50,000 shares at $2.93. Post-transaction, Cesano holds 56,700 shares.
- Puma Biotechnology director Alessandra Cesano sold 62,150 shares on Sep. 14, 2026 at USD 9.12 per share. * Trade followed the exercise of stock options for 50,000 shares at USD 2.93. * Cesano held 56,700 shares after the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-030593), on September 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here